China Cinda Asset Management Co., Ltd. (HKG:1359)

Theseus Pharmaceuticals Statistics

Total Valuation

HKG:1359 has a market cap or net worth of HKD 54.58 billion.

Market Cap	54.58B
Enterprise Value	n/a

Important Dates

The next estimated earnings date is Wednesday, August 27, 2025.

Earnings Date	Aug 27, 2025
Ex-Dividend Date	Jul 3, 2025

Share Statistics

HKG:1359 has 38.16 billion shares outstanding.

Current Share Class	13.57B
Shares Outstanding	38.16B
Shares Change (YoY)	n/a
Shares Change (QoQ)	-58.38%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	2.65%
Float	9.23B

Valuation Ratios

The trailing PE ratio is 34.55 and the forward PE ratio is 14.03.

PE Ratio	34.55
Forward PE	14.03
PS Ratio	2.22
PB Ratio	0.23
P/TBV Ratio	0.33
P/FCF Ratio	0.76
P/OCF Ratio	0.72
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.25, with a Debt / Equity ratio of 4.22.

Current Ratio	2.25
Quick Ratio	1.83
Debt / Equity	4.22
Debt / EBITDA	n/a
Debt / FCF	13.99
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 1.60%.

Return on Equity (ROE)	1.60%
Return on Assets (ROA)	0.22%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	1.78M
Profits Per Employee	114,359
Employee Count	13,815
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

In the past 12 months, HKG:1359 has paid 513.01 million in taxes.

Income Tax	513.01M
Effective Tax Rate	12.04%

Stock Price Statistics

The stock price has increased by +130.65% in the last 52 weeks. The beta is 0.46, so HKG:1359's price volatility has been lower than the market average.

Beta (5Y)	0.46
52-Week Price Change	+130.65%
50-Day Moving Average	1.30
200-Day Moving Average	1.22
Relative Strength Index (RSI)	53.57
Average Volume (20 Days)	224,475,430

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1359 had revenue of HKD 24.60 billion and earned 1.58 billion in profits. Earnings per share was 0.04.

Revenue	24.60B
Gross Profit	16.27B
Operating Income	8.66B
Pretax Income	4.26B
Net Income	1.58B
EBITDA	n/a
EBIT	n/a
Earnings Per Share (EPS)	0.04

Balance Sheet

The company has 605.79 billion in cash and 1.00 trillion in debt, giving a net cash position of -395.76 billion or -10.37 per share.

Cash & Cash Equivalents	605.79B
Total Debt	1.00T
Net Cash	-395.76B
Net Cash Per Share	-10.37
Equity (Book Value)	237.48B
Book Value Per Share	5.11
Working Capital	698.80B

Cash Flow

In the last 12 months, operating cash flow was 75.79 billion and capital expenditures -4.20 billion, giving a free cash flow of 71.59 billion.

Operating Cash Flow	75.79B
Capital Expenditures	-4.20B
Free Cash Flow	71.59B
FCF Per Share	1.88

Margins

Gross margin is 66.14%, with operating and profit margins of 35.21% and 13.14%.

Gross Margin	66.14%
Operating Margin	35.21%
Pretax Margin	17.32%
Profit Margin	13.14%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	291.05%

Dividends & Yields

This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 1.81%.

Dividend Per Share	0.03
Dividend Yield	1.81%
Dividend Growth (YoY)	-47.85%
Years of Dividend Growth	n/a
Payout Ratio	108.62%
Buyback Yield	n/a
Shareholder Yield	1.85%
Earnings Yield	2.89%
FCF Yield	131.18%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5